Early Trading Has Applied Dna (APDN) Climbing for September 6


Applied Dna Sciences Inc (NASDAQ:APDN) is active in pre-market trading today, September 6, with shares climbing 20.94% from the last closing price.



The stock is down 31.09% year-to-date while moving 4.81% loses over the last 5 days.



For technical charts, analysis, and more on Applied Dna visit the company profile.



Pre-market prices and movements as of 08:20:41 est.




About Applied Dna Sciences Inc

Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction (‘PCR’)-based manufacturing platform that allows for the large-scale production of specific DNA sequences. The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies. Applied DNA has also established a COVID-19 diagnostic and testing offering that is in the early stages of commercialization and is grounded in the Company’s deep expertise in DNA. The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.



To get more information on Applied Dna Sciences Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Applied Dna Sciences Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Fix from Equities News to receive the best stories to your inbox.Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE:
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: www.equities.com/disclaimer


The Ultimate Truth Serum
The Era Of Low Inflation May Be Over. Are Commodities The Solution?
Qualcomm’s Metaverse Opportunity is Coming into Focus: Jeff Kagan
The Disruptor You Can’t Live Without
Can T-Mobile Hold Its Position as a Nasdaq Top Performer? Jeff Kagan
Three Reasons to Reload on Raw Material Investments
Nuclear Power Is Gaining New Respect in Europe. It’s About Time
Why Gold Mining Stocks Could Be the Ultimate Contrarian Play



Read more here: Source link